121 related articles for article (PubMed ID: 16078986)
1. Association between risperidone treatment and cerebrovascular adverse events in elderly patients with dementia.
Formiga F; Fort I; Pérez-Castejón JM; Ruiz D; Duaso E; Riu S
J Am Geriatr Soc; 2005 Aug; 53(8):1446-8. PubMed ID: 16078986
[No Abstract] [Full Text] [Related]
2. Antipsychotics and risk of cerebrovascular events in treatment of behavioural and psychological symptoms of dementia in Hong Kong: a hospital-based, retrospective, cohort study.
Chan MC; Chong CS; Wu AY; Wong KC; Dunn EL; Tang OW; Chan WF
Int J Geriatr Psychiatry; 2010 Apr; 25(4):362-70. PubMed ID: 19650162
[TBL] [Abstract][Full Text] [Related]
3. Association between risperidone treatment and cerebrovascular adverse events: examining the evidence and postulating hypotheses for an underlying mechanism.
Smith DA; Beier MT
J Am Med Dir Assoc; 2004; 5(2):129-32. PubMed ID: 15008183
[No Abstract] [Full Text] [Related]
4. Mortality in elderly dementia patients treated with risperidone.
Haupt M; Cruz-Jentoft A; Jeste D
J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
[TBL] [Abstract][Full Text] [Related]
6. Bradycardia at low doses of risperidone.
Tran KT; Golden P; Lark T; Jacob NJ
Am J Psychiatry; 2004 Dec; 161(12):2325-6. PubMed ID: 15569911
[No Abstract] [Full Text] [Related]
7. [Changeover to risperidone after treatment with conventional low potency neuroleptics in dementia patients. An observation study during usage].
Stoppe G; Schreiner A; Schmitt AB
Dtsch Med Wochenschr; 2006 Mar; 131(9):423-9. PubMed ID: 16493564
[TBL] [Abstract][Full Text] [Related]
8. Risperidone questioned as dementia first-line treatment.
Saxe T
Geriatrics; 2004 Feb; 59(2):11; author reply 11-2. PubMed ID: 14989589
[No Abstract] [Full Text] [Related]
9. How safe are antipsychotics in dementia?
BMJ Group
Drug Ther Bull; 2007 Nov; 45(11):81-5. PubMed ID: 18165678
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
Suh GH; Greenspan AJ; Choi SK
Int J Geriatr Psychiatry; 2007 May; 22(5):494-5. PubMed ID: 17471597
[No Abstract] [Full Text] [Related]
11. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
Curran S; Turner D; Musa S; Wattis J
Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
[TBL] [Abstract][Full Text] [Related]
12. Hypothermia in a patient receiving risperidone and paroxetine.
Al Chekakie MO; Ketz JM; Whinney CM
J Clin Psychopharmacol; 2006 Jun; 26(3):332-3. PubMed ID: 16702902
[No Abstract] [Full Text] [Related]
13. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A
Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159
[TBL] [Abstract][Full Text] [Related]
14. Baseline characteristics and treatment-emergent risk factors associated with cerebrovascular event and death with risperidone in dementia patients.
Howard R; Costafreda SG; Karcher K; Coppola D; Berlin JA; Hough D
Br J Psychiatry; 2016 Nov; 209(5):378-384. PubMed ID: 27388570
[TBL] [Abstract][Full Text] [Related]
15. A biological basis for the sex bias of antipsychotic drugs adverse events.
Gurwitz D; Morag A; Oved K
J Am Geriatr Soc; 2013 Aug; 61(8):1437. PubMed ID: 23937507
[No Abstract] [Full Text] [Related]
16. Risperidone for the treatment of neuropsychiatric features in dementia.
Burns A; De Deyn PP
Drugs Aging; 2006; 23(11):887-96. PubMed ID: 17109567
[TBL] [Abstract][Full Text] [Related]
17. [Risperidone and cerebrovascular adverse effects in elderly patients with dementia].
Formiga F; Fort I; Pérez-Castejón JM; Ruiz D; Duaso E; Riu S
Rev Clin Esp; 2006 Sep; 206(8):411-2; author reply 412-3. PubMed ID: 16863635
[No Abstract] [Full Text] [Related]
18. Agitation and psychosis in dementia.
Ballard C
Am J Geriatr Psychiatry; 2007 Nov; 15(11):913-7. PubMed ID: 17974863
[No Abstract] [Full Text] [Related]
19. [Neuroleptic malignant syndrome in users of risperidone].
Bonte-Mineur F; Geerlings CJ; Rietveld AP
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):158-9; author reply 159. PubMed ID: 15693595
[No Abstract] [Full Text] [Related]
20. Are there any news about the antipsychotic medications in the elderly?
Cucinotta D; Minardi M; Lanfranchi G; Reggiani A; Savorani G
Arch Gerontol Geriatr; 2007; 44 Suppl 1():133-7. PubMed ID: 17317446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
